Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions.T. J. de Vries, G N van Muijen, D. J. Ruiter et al.|PubMed|1997Cited by 191
Reproducibility of detection of tyrosinase and MART-1 transcripts in the peripheral blood of melanoma patients: a quality control study using real-time quantitative RT-PCRT. J. de Vries, Goos N.P. van Muijen, Th. Wobbes et al.|British Journal of Cancer|1999Cited by 78
Expression of immunotherapy candidate proteins GP100, Mart-1/Melan-A and tyrosinase in human melanocytic lesions and melanoma cell linesT. J. de Vries, Muijen GNP van, A Fourkour et al.|Melanoma Research|1997Cited by 14
Analysis of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction for tyrosinase and MART-1 after mononuclear cell collection with cell preparation tubes: a comparison with the whole blood guanidinium isothiocyanate RNA isolation methodT. J. de Vries, Goos N.P. van Muijen, A Fourkour et al.|Melanoma Research|2000Cited by 14
Melanoma-inhibiting activity (MIA) mRNA is not exclusively transcribed in melanoma cells: low levels of MIA mRNA are present in various cell types and in peripheral bloodTeun J. de Vries, Goos N.P. van Muijen, H. Diepstra et al.|British Journal of Cancer|1999Cited by 13